Blood flow specialist Deltex Medical Group plc (LON:DEMG) has launched a new, more accurate disposable Oesophageal Doppler monitoring (ODM) probe.
The reconfigured probe tip design creates a wider ultrasound beam at the focal point in the aorta, helping it to focus substantially better, even when the patient's position is changed.
The new TruFlow probe has been used in all new evaluations in the US since November.
Ewan Phillips, chief executive, said: "The new wider beam of the TruFlow probes are a major step-forward for Deltex as making the proven ODM technology even easier to use, reduces perceived barriers to change in clinical practice and further reduces the clinical support needed before new customers become independent users."
Used during and after surgery, Deltex’s ODM systems use a low-frequency ultrasound signal that is highly sensitive to changes in blood flow and measures them immediately.
The company says early fluid management intervention reduces post-operative complications, intensive care admissions and the length of hospital stay.